Blake Borgeson, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 170,000 shares at $3.46 ($588K) on 2026-03-03, disclosed to the SEC on 2026-03-04.
Open-market sale of $588k RXRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RXRX | SELL | 2026-08-06 | $98K | — | Filing → |
| RXRX | SELL | 2026-07-09 | $159K | — | Filing → |
| RXRX | SELL | 2026-06-04 | $110K | — | Filing → |